MedTrace Logo

Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases

NCT01445483 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2026-05-19

No results posted yet for this study

Summary

Background:

* There are no standardized sets of tests to measure changes in neuropsychological functioning in patients treated for brain metastasis (cancer that has spread beyond the original site to the brain).
* Neuropsychological function has an important effect on quality of life and should be included when determining treatment options.

Objectives:

* To find out if there is a change in patients cognitive (thinking) and daily functioning after standard radiation treatment for brain metastasis that can be measured with tests.
* To see if any changes on these tests are related to patients response to radiation therapy.

Eligibility:

\- Patients 18 years of age or older who have cancer that has spread to the brain.

Design:

* Patients receive a 2-week course of radiation therapy to the brain, given daily 5 days a week. Some patients may require stereotactic radiosurgery (an additional boost of radiation therapy to specific sites of brain metastasis).
* Patients have the following evaluations before and after treatment to determine changes in cognition and functioning:
* Neuropsychological testing to measure cognitive (thinking) abilities like memory, attention, processing speed, and reading, and fine motor skills.
* Questionnaires to assess quality of life and daily living skills.
* Patients have MRI scans and blood and urine tests.
* At the completion of radiation treatment, patients return to the clinic for follow-up visits at 1, 2, 4, 6, 9 and 12 months for blood and urine tests, physical examination, MRI of the brain, neuropsychological testing and assessments of quality of life and daily living skills.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • DeeDee K Smart, M.D. · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01445483 on ClinicalTrials.gov